drug

GEN1042

1 story · latest Jul 2, 2026

Status: Investigational
Trials: 3 registered trials in coverage

Relationships

Developed by Genmab A/S

Timeline

Genmab-BioNTech trial of GEN1042 combos posts results after early end for lack of efficacy

Jul 2Trial updateBioNTech SE GEN1042

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.